Adjust Medical SA

Adjust Medical is a Geneva-based medical device startup dedicated to revolutionize the treatment of mitral valve regurgitation with its Medical Device the AdjusTer". Mitral valve regurgitation, the most common heart valve pathology, affects millions of patients globally and, if left untreated, can lead to heart failure and death. Conventional treatments often involve invasive surgery or complex, bulky, minimally-invasive devices that denature the native mitral valve, modify the physiological blood flow, render adoption difficult, and limit subsequent treatment options. Adjust Medicals breakthrough product, the AdjusTer", addresses these limitations and the company aims to position itself as a "first-line" treatment in a rapidly expanding multi-billion-dollar market.